Indicaton

CAL02 is a first-in-class broad-spectrum anti-virulence agent for the treatment and prevention of complications associated with severe or resistant infections. First-in-man clinical trial in patients completed.

Type of product
Table
  • Phase

    Phase I completed

  • Available in

    WW